Dominick Colangelo - 23 Jun 2022 Form 4/A - Amendment Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role
Director
Signature
/s/ Christopher Galletta, attorney-in-fact
Issuer symbol
TRVI
Transactions as of
23 Jun 2022
Transactions value $
$0
Form type
4/A - Amendment
Filing time
01 Jul 2022, 16:54:52 UTC
Date Of Original Report
23 Jun 2022
Previous filing
22 Feb 2022
Next filing
12 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRVI Nonstatutory Stock Option (right to buy) Award $0 +20K $0.00 20K 23 Jun 2022 Common Stock 20K $2.27 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 23, 2022. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.
F2 This amendment to the Form 4 originally filed for the reporting person on June 23, 2022 is being filed solely to attach the power of attorney exhibit that was inadvertently excluded from the original filing.

Remarks:

Exhibit Index: 24 Power of Attorney